• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

量化重度糖尿病视网膜病变且视力良好患者全视网膜光凝治疗前后黄斑厚度的变化。

Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.

作者信息

Shimura Masahiko, Yasuda Kanako, Nakazawa Toru, Kano Tetsuya, Ohta Satsuki, Tamai Makoto

机构信息

Department of Ophthalmology, Tohoku Graduate School of Medicine, Sendai, Japan.

出版信息

Ophthalmology. 2003 Dec;110(12):2386-94. doi: 10.1016/j.ophtha.2003.05.008.

DOI:10.1016/j.ophtha.2003.05.008
PMID:14644723
Abstract

PURPOSE

To investigate the alterations of macular thickness during and after panretinal photocoagulation (PRP) in patients with severe diabetic retinopathy and good vision, and to compare the outcomes of weekly and biweekly treatments.

DESIGN

Prospective, comparative interventional case series.

PARTICIPANTS

Thirty-six patients with severe nonproliferative diabetic retinopathy or non-high-risk proliferative diabetic retinopathy whose visual acuity was 20/20 or better before PRP.

METHODS

Seventy-two eyes of 36 patients underwent scatter PRP in 4 sessions. The macular thickness was measured by optical coherence tomography. The photocoagulation sessions were performed weekly to one eye and biweekly to the other eye. Each eye was selected at random.

MAIN OUTCOME MEASURES

Best-corrected visual acuity and macular thickness.

RESULTS

Visual acuities were maintained in 89% of eyes with weekly treatments and 92% of eyes with biweekly treatments. Macular thickness was increased transiently in the central macula in both eyes, more in the weekly treated eyes, and then decreased to control levels in eyes treated biweekly but remained thickened in eyes treated weekly.

CONCLUSION

For eyes with severe diabetic retinopathy and good vision, PRP with either weekly or biweekly treatment did not affect postoperative visual acuity. However, biweekly treatments allowed faster recovery of macular thickening after PRP than weekly treatments.

摘要

目的

研究重度糖尿病视网膜病变且视力良好的患者在全视网膜光凝(PRP)期间及之后黄斑厚度的变化,并比较每周治疗和每两周治疗的效果。

设计

前瞻性、比较性干预病例系列研究。

研究对象

36例重度非增殖性糖尿病视网膜病变或非高危增殖性糖尿病视网膜病变患者,其在PRP治疗前视力为20/20或更好。

方法

36例患者的72只眼分4次进行了散在PRP治疗。通过光学相干断层扫描测量黄斑厚度。一只眼每周进行一次光凝治疗,另一只眼每两周进行一次光凝治疗。每只眼随机选择治疗方式。

主要观察指标

最佳矫正视力和黄斑厚度。

结果

每周治疗的眼中89%以及每两周治疗的眼中92%的视力得以维持。双眼黄斑中心厚度均出现短暂增加,每周治疗的眼增加得更多,之后每两周治疗的眼黄斑厚度降至对照水平,而每周治疗的眼黄斑厚度仍保持增厚。

结论

对于重度糖尿病视网膜病变且视力良好的眼,每周或每两周进行一次PRP治疗均不影响术后视力。然而,与每周治疗相比,每两周治疗使PRP后黄斑增厚恢复得更快。

相似文献

1
Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.量化重度糖尿病视网膜病变且视力良好患者全视网膜光凝治疗前后黄斑厚度的变化。
Ophthalmology. 2003 Dec;110(12):2386-94. doi: 10.1016/j.ophtha.2003.05.008.
2
Changes in macular thickness after panretinal photocoagulation in patients with severe diabetic retinopathy and no macular edema.严重糖尿病视网膜病变且无黄斑水肿患者行全视网膜光凝后黄斑厚度的变化。
Retina. 2010 May;30(5):756-60. doi: 10.1097/IAE.0b013e3181c701e0.
3
Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.重度糖尿病视网膜病变且视力良好的患者接受全视网膜光凝术后的视觉功能障碍
Am J Ophthalmol. 2005 Jul;140(1):8-15. doi: 10.1016/j.ajo.2005.02.029.
4
Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.后Tenon囊下注射曲安奈德可预防严重糖尿病视网膜病变且视力良好患者的全视网膜光凝所致视觉功能障碍。
Ophthalmology. 2006 Mar;113(3):381-7. doi: 10.1016/j.ophtha.2005.10.035. Epub 2006 Feb 3.
5
Temporal variation in diabetic macular edema measured by optical coherence tomography.通过光学相干断层扫描测量的糖尿病性黄斑水肿的时间变化。
Ophthalmology. 2004 Feb;111(2):211-7. doi: 10.1016/j.ophtha.2003.05.031.
6
Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.使用光学相干断层扫描分析糖尿病患者白内障手术后的黄斑水肿。
Ophthalmology. 2007 May;114(5):881-9. doi: 10.1016/j.ophtha.2006.08.053. Epub 2007 Feb 1.
7
Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.玻璃体内注射贝伐单抗(阿瓦斯汀)预防严重增殖性糖尿病视网膜病变患者全视网膜光凝引起的并发症。
Retina. 2008 Oct;28(9):1319-24. doi: 10.1097/IAE.0b013e31818356fb.
8
Effect of panretinal photocoagulation on choroidal circulation in the foveal region in patients with severe diabetic retinopathy.全视网膜光凝对重度糖尿病视网膜病变患者黄斑区脉络膜循环的影响。
Br J Ophthalmol. 2008 Oct;92(10):1369-73. doi: 10.1136/bjo.2007.136028. Epub 2008 Jul 28.
9
[Panretinal photocoagulation with or without focal photocoagulation--the effect on central retinal thickness].全视网膜光凝联合或不联合局灶性光凝——对视网膜中央厚度的影响
Oftalmologia. 2010;54(2):99-103.
10
Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.改良格栅激光光凝术与玻璃体切割联合内界膜剥除术治疗糖尿病性黄斑水肿的比较
Am J Ophthalmol. 2005 May;139(5):795-801. doi: 10.1016/j.ajo.2004.12.017.

引用本文的文献

1
The Effect of Pan-Retinal Photocoagulation on Central Macular Thickness in a Sample of Iraqi Patients With Proliferative Diabetic Retinopathy.全视网膜光凝对伊拉克增殖性糖尿病视网膜病变患者样本中心黄斑厚度的影响。
Cureus. 2024 Aug 23;16(8):e67616. doi: 10.7759/cureus.67616. eCollection 2024 Aug.
2
Efficacy of intravitreal conbercept combined with panretinal photocoagulation for severe nonproliferative diabetic retinopathy without macular edema.玻璃体内注射康柏西普联合全视网膜光凝治疗无黄斑水肿的重度非增殖性糖尿病视网膜病变的疗效
Int J Ophthalmol. 2022 Apr 18;15(4):615-619. doi: 10.18240/ijo.2022.04.15. eCollection 2022.
3
Evaluation of contrast sensitivity in non-high-risk proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal injections of ranibizumab.
在接受全视网膜光凝治疗且接受或未接受玻璃体内注射雷珠单抗的非高危增殖性糖尿病视网膜病变患者中对比敏感度的评估。
Arq Bras Oftalmol. 2022 Jan-Feb;85(1):37-45. doi: 10.5935/0004-2749.20220006.
4
Central Macular Thickness in Diabetic Macular Edema.糖尿病性黄斑水肿中的中心黄斑厚度
Acta Endocrinol (Buchar). 2020 Oct-Dec;16(4):417-425. doi: 10.4183/aeb.2020.417.
5
Synergistic interactions of PlGF and VEGF contribute to blood-retinal barrier breakdown through canonical NFκB activation.PlGF 和 VEGF 的协同作用通过经典 NFκB 激活促进血视网膜屏障破坏。
Exp Cell Res. 2020 Dec 15;397(2):112347. doi: 10.1016/j.yexcr.2020.112347. Epub 2020 Oct 29.
6
Evaluation of Laser Effects on the Human Body After Laser Therapy.激光治疗后激光对人体影响的评估。
J Lasers Med Sci. 2020 Winter;11(1):91-97. doi: 10.15171/jlms.2020.15. Epub 2020 Jan 18.
7
Advances in Retinal Laser Therapy.视网膜激光治疗的进展
Int J Ophthalmic Res. 2018;4(1):259-264. doi: 10.17554/j.issn.2409-5680.2018.04.70. Epub 2018 Feb 27.
8
Effects of panretinal photocoagulation on retinal vasculature and foveal avascular zone in diabetic retinopathy using optical coherence tomography angiography: A pilot study.使用光学相干断层扫描血管造影术评估全视网膜光凝对糖尿病性视网膜病变患者视网膜血管系统及黄斑无血管区的影响:一项初步研究。
J Curr Ophthalmol. 2019 Jul 3;31(3):287-291. doi: 10.1016/j.joco.2019.06.001. eCollection 2019 Sep.
9
Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab.最初接受玻璃体内注射贝伐单抗治疗的无黄斑水肿的高危增殖性糖尿病视网膜病变患者眼内新生血管消退的时间
Clin Ophthalmol. 2018 Dec 19;13:27-31. doi: 10.2147/OPTH.S182420. eCollection 2019.
10
The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy.抗血管内皮生长因子(抗VEGF)在增殖性糖尿病视网膜病变治疗中的作用。
Drugs Context. 2018 Aug 13;7:212532. doi: 10.7573/dic.212532. eCollection 2018.